Cyclic peptides sit behind some of the most interesting molecules in modern drug discovery. Closing a peptide into a ring can dramatically improve stability and target selectivity — but each cyclization strategy carries its own chemistry and manufacturing implications. Here is how the main methods work and what they mean for production.
Why cyclize a peptide?
Linear peptides are flexible and quickly degraded by proteases. Constraining them into a ring locks a defined conformation, which can boost binding affinity and selectivity, improve metabolic stability, and sometimes enhance membrane permeability. Those gains make cyclic peptides a powerful class — and a demanding one to make as part of custom peptide synthesis.
Methods of cyclization
- Head-to-tail (backbone): the N- and C-termini are joined to form a macrocycle.
- Side-chain to side-chain: e.g. lactam bridges between Lys and Asp/Glu residues.
- Disulfide bonds: cysteine pairs oxidised to form one or more bridges; multiple disulfides require careful regioselective folding.
- Stapled peptides: hydrocarbon staples that lock helical structure.
- Click and other chemistries: azide-alkyne and related ligations for defined linkages.
On-resin vs solution cyclization
Cyclization can be performed while the peptide is still on the resin or after cleavage in solution. On-resin cyclization benefits from pseudo-dilution that favours the ring over polymerisation; solution-phase cyclization is sometimes necessary but must manage dilution to avoid oligomers. The right choice depends on the sequence and the bond being formed.
Key point: the hardest part of cyclic peptides is often not forming the ring but doing so cleanly and reproducibly — and proving it, which demands strong analytics.
Manufacturing challenges
Cyclization adds steps, can lower yield, and frequently produces isomers or oligomers that must be separated by preparative HPLC and confirmed by orthogonal analytical methods. Disulfide-rich peptides need controlled folding to get the correct connectivity. These factors raise complexity and cost, and they make a thoughtful scale-up plan essential.